In the human AD brain and tauopathy mouse model, C1q levels were positively correlated with tau aggregation, and C3-C3aR1 expressions were increased proportional to the progression of tau pathology harming the cognitive function [45,46]. This evidence concerns the gene MAPT and Alzheimer disease.